Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Potkul

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Gynecologic Oncology|August 1, 1997
Regulation of human papillomavirus type 18 in vivo: effects of estrogen and progesterone in transgenic miceD Michelin, L Gissmann, D Street, et al.
American Journal of Obstetrics and Gynecology|April 1, 1989
A phase I/II study of intraperitoneally administered doxorubicin entrapped in cardiolipin liposomes in patients with ovarian cancerG Delgado, R K Potkul, J A Treat, et al.
Cancer|January 28, 1998
A phase II study of irinotecan (CPT-11) in patients with advanced squamous cell carcinoma of the cervixW P Irvin, F V Price, H Bailey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
A phase I clinical trial and pharmacokinetic evaluation of liposome-encapsulated doxorubicinA Rahman, J Treat, J K Roh, et al.
Spatial and Spatio-Temporal Epidemiology|February 15, 2025
Spatial modeling and risk assessment of chagas disease vector distribution in Espírito Santo, Brazil: A comprehensive approach for targeted controlStefanie Barbosa Potkul Soares, Gustavo Rocha Leite, Guilherme Sanches Corrêa-do-Nascimento, et al.
Journal of the National Cancer Institute|November 7, 1990
Antitumor activity of liposome-encapsulated doxorubicin in advanced breast cancer: phase II studyJ Treat, A Greenspan, D Forst, et al.
Gynecologic Oncology|June 1, 1995
A phase II trial of high-dose mitoxantrone, carboplatin, and cyclophosphamide with autologous bone marrow rescue for recurrent epithelial ovarian carcinoma: analysis of risk factors for clinical outcomeP Stiff, R Bayer, M Camarda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: a multivariate analysis of survival for 100 consecutively treated patientsP J Stiff, R Bayer, C Kerger, et al.
American Journal of Cancer Research|November 18, 2024
Cabozantinib inhibits tumor growth in mice with ovarian cancerPatrick J Stiff, Elizabeth Kertowidjojo, Ronald K Potkul, et al.
Gynecologic Oncology|May 1, 1997
Interferon-gamma enhances susceptibility of cervical cancer cells to lysis by tumor-specific cytotoxic T cellsD Street, A M Kaufmann, A Vaughan, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Gynecologic Oncology|August 1, 1997
Regulation of human papillomavirus type 18 in vivo: effects of estrogen and progesterone in transgenic miceD Michelin, L Gissmann, D Street, et al.
American Journal of Obstetrics and Gynecology|April 1, 1989
A phase I/II study of intraperitoneally administered doxorubicin entrapped in cardiolipin liposomes in patients with ovarian cancerG Delgado, R K Potkul, J A Treat, et al.
Cancer|January 28, 1998
A phase II study of irinotecan (CPT-11) in patients with advanced squamous cell carcinoma of the cervixW P Irvin, F V Price, H Bailey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
A phase I clinical trial and pharmacokinetic evaluation of liposome-encapsulated doxorubicinA Rahman, J Treat, J K Roh, et al.
Spatial and Spatio-Temporal Epidemiology|February 15, 2025
Spatial modeling and risk assessment of chagas disease vector distribution in Espírito Santo, Brazil: A comprehensive approach for targeted controlStefanie Barbosa Potkul Soares, Gustavo Rocha Leite, Guilherme Sanches Corrêa-do-Nascimento, et al.
Journal of the National Cancer Institute|November 7, 1990
Antitumor activity of liposome-encapsulated doxorubicin in advanced breast cancer: phase II studyJ Treat, A Greenspan, D Forst, et al.
Gynecologic Oncology|June 1, 1995
A phase II trial of high-dose mitoxantrone, carboplatin, and cyclophosphamide with autologous bone marrow rescue for recurrent epithelial ovarian carcinoma: analysis of risk factors for clinical outcomeP Stiff, R Bayer, M Camarda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: a multivariate analysis of survival for 100 consecutively treated patientsP J Stiff, R Bayer, C Kerger, et al.
American Journal of Cancer Research|November 18, 2024
Cabozantinib inhibits tumor growth in mice with ovarian cancerPatrick J Stiff, Elizabeth Kertowidjojo, Ronald K Potkul, et al.
Gynecologic Oncology|May 1, 1997
Interferon-gamma enhances susceptibility of cervical cancer cells to lysis by tumor-specific cytotoxic T cellsD Street, A M Kaufmann, A Vaughan, et al.
Pageof 7